ekonominyheter

TranslateRSSMobil
ImmunoGen, Inc. Pushes Forward

ImmunoGen, Inc. Pushes Forward

Fool.com 24/10 13:42

With just $4.2 million in royalties from Roche's Kadcyla, investors need to be focused on ImmunoGen's internal pipeline.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status